MedTrace Logo

National Study on Autism Spectrum Disorder in China

NCT02200679 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 143755

Last updated 2017-05-16

No results posted yet for this study

Summary

The aims of the national population-based study on Autism Spectrum Disorder (ASD) include: (1) to understand the overall prevalence of ASD in children aged 6-12 years in 8 cities (n=120,000), (2) to explore environmental and genetic risk factors associated with ASD

Conditions

  • Autism Spectrum Disorders

Sponsors & Collaborators

  • National Health and Family Planning Commission, P.R.China

    collaborator OTHER_GOV

  • Fudan University

    lead OTHER

Principal Investigators

  • Yi Wang, PhD,MD · Children's Hospital of Fudan University

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02200679 on ClinicalTrials.gov